ENVB
Enveric Biosciences·NASDAQ
--
--(--)
--
--(--)
7.29 / 10
Outperform
Analyst coverage is missing (ana_eval = -1). Fund‑flow metrics are favorable, scoring 7.29/10, with positive small‑ and extra‑large‑investor inflows. However, overall, block, medium and large inflow trends are negative, suggesting mixed sentiment despite strong net inflow ratios.
Fund Flow Rating
What is the market sentiment for ENVB?
- ENVB holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.29/10 (Outperform).
